- Home
- DFP vs CYRX Comparison
DFP vs CYRX Comparison
Compare DFP & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DFP | CYRX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.5M | 419.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | DFP | CYRX |
|---|---|---|
| Price | $20.96 | $15.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 43.2K | ★ 714.9K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.56 | $6.69 |
| 52 Week High | $22.11 | $16.89 |
Technical Indicators
Market Signals| Indicator | DFP | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 51.97 |
| Support Level | $20.81 | $14.51 |
| Resistance Level | $20.99 | $16.69 |
| Average True Range (ATR) | 0.14 | 0.73 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 70.34 | 44.22 |
Price Performance
Historical ComparisonAbout DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.